January 11, 2018 Columns by Laura Kolaczkowski My Ocrevus Treatments: The Next Round Is Delayed By now, I had planned to give you an update on my current multiple sclerosis disease-modifying therapy Ocrevus (ocrelizumab). But one thing living with multiple sclerosis teaches us is to not count on plans always…
December 21, 2017 Columns by Laura Kolaczkowski My Holiday Gift Wish It’s that time of year when everyone is asking: What would you like for Christmas? Shopping for the perfect gift for me is a challenge because I’ve been around long enough to have most of the things I…
December 7, 2017 Columns by Laura Kolaczkowski Advances in MRI Readings My neurologist orders an annual MRI to see if any major changes have occurred, and last year my imaging included NeuroQuant software. NeuroQuant is still relatively unknown in the multiple sclerosis patient community. It is a measuring software…
November 16, 2017 Columns by Laura Kolaczkowski A JC Virus Primer There is often alarm and confusion about the JC virus, how we get it, and what it means to people with multiple sclerosis. This is my quick primer to help address these questions in a very basic way.
November 9, 2017 Columns by Laura Kolaczkowski Ocrevus Q&A, Part 2 Editor’s note: This is the second of a two-part series on readers’ comments about Ocrevus (ocrelizumab). Read part one here. Last week, I responded to a few comments on columns regarding my personal experience with…
November 2, 2017 Columns by Laura Kolaczkowski Ocrevus Q&A, Part 1 Editor’s Note: First in a two-part series on readers’ comments about Ocrevus (ocrelizumab). I switched disease-modifying therapies and began treatment with Ocrevus (ocrelizumab) in June. I previously wrote about my reasons for switching, my experiences…
October 19, 2017 Columns by Laura Kolaczkowski How Doctors’ Gender Can Influence Opinions on Healthcare Quality There are two doctors. Here’s your choice: One has a patient-centered approach to care, spends more time with you during appointments, and is more empathetic with your concerns. On average, patients under this doctor live longer. The…
October 12, 2017 Columns by Laura Kolaczkowski Did You Wash Your Hands? I’ve been at a conference the last few days where scholars from around the world are discussing health literacy. It’s a subject much more complicated than just wondering at what level a person might read, or if…
October 5, 2017 Columns by Laura Kolaczkowski Discovering MS Research When talking about MS research, we tend to focus on drug development because improved therapies, and even the cure for MS, will come from pharmaceuticals. But what do we know about other MS research that doesn’t involve…
September 28, 2017 Columns by Laura Kolaczkowski A Look Inside MS Marketplace Projections Do you ever stop and ponder the value of MS drugs? I’m not talking about if they work and the ways they improve our lives. I’m thinking of the COST of them and what their pricing means to…
September 14, 2017 Columns by Laura Kolaczkowski There’s an App (Maybe Too Many) for That! How many hours do the pharmaceutical companies think we have in our day? I ask because almost all of them have come up with very slick tools to use, particularly mobile apps, to help us improve our…
September 7, 2017 Columns by Laura Kolaczkowski #Sleeptember is Here! What better time of year to talk about getting good sleep than heading into the fall season, which is followed by the dark days of winter? Although we are not furry creatures who curl up in a cave to…
April 25, 2024 Columns by Benjamin Hofmeister Finding safety while living with the constant threat of MS progression
April 22, 2024 Columns by Desiree Lama Learning to manage cognitive impairment with multiple sclerosis
April 18, 2024 Columns by Benjamin Hofmeister Learning how to write a ‘SOAP’ note feels different after an MS diagnosis